CRL vs HUT · rev $2.00B vs rev $235.1M
Charles River Laboratories (CRL) versus Hut 8 Corp. Common Stock (HUT) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Hut 8 Corp. Common Stock (HUT) is a capital markets company listed on US.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported HUT revenue for 2025-12-31 was $235.1M. Net income was -$226.1M. Revenue was up 44.8% from 2024-12-31 to 2025-12-31. HUT currently screens at market cap $12.64B.
CRL currently screens at market cap $7.78B. HUT currently screens at market cap $12.64B.
Not investment advice. Open the CRL and HUT stock pages for the full models.
Not investment advice.